维普中文期刊产品整合服务
19篇 您的检索式:作者名="Tulic C"
    题名 作者 年代 出处 被引量
1Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy显示文摘AIM To study the innate immune function in ulcerative colitis(UC) patients who fail to respond to anti-tumor necrosis factor(TNF) therapy.METHODS Effects of anti-TNF therapy, inflammation and medications on innate immune function were assessed by measuring peripheral blood mononuclear cell(PBMC) cytokine expression from 18 inflammatory bowel disease patients pre- and 3 mo post-anti-TNF therapy. Toll-like receptor(TLR) expression and cytokine production post TLR stimulation was assessed in UC 'responders'(n = 12) and 'non-responders'(n = 12) and compared to healthy controls(n = 12). Erythrocyte sedimentation rate(ESR) and C-reactive protein(CRP) levels were measured in blood to assess disease severity/activity and inflammation. Pro-inflammatory(TNF, IL-1β, IL-6), immuno-regulatory(IL-10), Th1(IL-12, IFNγ) and Th2(IL-9, IL-13, IL-17A) cytokine expression was measured with enzyme-linked immunosorbent assay while TLR cellular composition and intracellular signalling was assessed with FACS.RESULTS Prior to anti-TNF therapy, responders and nonresponders had similar level of disease severity and activity. PBMC's ability to respond to TLR stimulation was not affected by TNF therapy, patient's severity of the disease and inflammation or their medication use. At baseline, non-responders had elevated innate but not adaptive immune responses compared to responders(P < 0.05). Following TLR stimulation, nonresponders had consistently reduced innate cytokine responses to all TLRs compared to healthy controls(P < 0.01) and diminished TNF(P < 0.001) and IL-1β(P < 0.01) production compared to responders. This innate immune dysfunction was associated with reduced number of circulating plasmacytoid dendritic cells(p DCs)(P < 0.01) but increased number of CD4+ regulatory T cells(Tregs)(P = 0.03) as well as intracellular accumulation of IRAK4 in non-responders following TLR-2,-4 and-7 activation(P < 0.001). CONCLUSION Reduced innate immunity in non-responders may explain reduced efficacy to anti-TNF therapy. These serological markers may prove useful in predicting the outcome of costly anti-TNF therapy.Angela C Baird Dominic Mallon Graham Radford-Smith Julien Boyer Thierry Piche Susan L Prescott Ian C Lawrance Meri K Tulic 2016World Journal of Gastroenterology2016,22,41:10
2Tools used to measure airway remodelling in research显示文摘Bergeron C Tulic MK Hamid Q 2007Eur Respir J2007,29,10:1
3Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-ind,ucible protein 10 expression in asthmatic airway mucosa显示文摘Fukakusa M Bergeron C Tulic MK 2005Allergy Clin Immunol2005,115,2:1
4Airway remodelling in asthma: frombenchside to clinical practice显示文摘Bergeron C Tulic M K Hamid Q 2010Can Respir J2010,17,4:1
5Tools used to measure airway remodeling in resesrch 显示文摘Bergeron C Tulic MK Hamid Q 2007Eur Respir J2007,29,3:1
6Tools used to measure airway remodelling in research 显示文摘Bergeron C Tulic MK Hamid Q 2007Eur Respir J2007,29,3:1
7Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil,IL-8,and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa显示文摘FUKAKUSA M BERGERON C TULIC MK 2005J Allergy Clin Immunol2005,115,2:1
8Results of application of orthotopic urine diversion according to Studer显示文摘Acimovic M Tulic C Dzamic Z 2007Acta Chir Iugosl2007,54,4:1
9Oral corti- costeroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa显示文摘FUKAKUSA M BERGERON C TULIC MK et ol 2005J Allergy Clin Immunol2005,115,2:1
10Airway remodelling in asthma: from benehside to clinical practice显示文摘Bergeron C Tulic M K Hamid Q 2010Can Respir J2010,17,4:1
11Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil,IL-8,and IFN-γ-inducible protein-10 expression in asthmatic airway mucosa显示文摘Fukakusa M Bergeron C Tulic MK 2005J Allergy Clin Immunol2005,115,2:1
12Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrephil, IL- 8, and IFN-γ- inducible protein -10 expression in asthmatic airway mucosa 显示文摘Fukakusa M Bergeron C Tulic MK 2005Allergy Clin lmmunol2005,115,2:1
13Polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide 显示文摘Tulic M K Hurrelbrink R J Prele C M 2007J Immunol2007,179,1:1
14Oral corticosteroids decrease eoainophil and CC chemokine expression but increase neutrophil,IL-2,and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa显示文摘Fukaktusa M Bergeron C Tulic MK 2005Allergy Clin Immunol2005,115,2:1
15Oral corticosterolds decrease eosinophll and CC chemoklne expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa显示文摘FUKAKUSA M BERGERON C TULIC M K 2005J Allergy Clin Immumol2005,115,2:1
16Airway remodelling in asthma: from benchside to clinical practice 显示文摘Bergeron C Tulic MK Hamid Q 2010Can Respir J2010,17,4:1
17Airway remodelling in asthma:from benchside to clinical practice显示文摘Bergeron C Tulic MK Hamid Q 0,,:1
18Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil,IL-8, and IFN-γ-inducible protein-10 expression in asthmaric airway mucosa 显示文摘Fukakusa M Bergeron C Tulic MK 2005J Allergy Clin Immunol2005,115,:1
19Airway remodeling in asthma:from benchside to clinical practice 显示文摘Bergeron C Tulic M K Hamid Q 2010Can Respir J2010,17,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费